• 105586+ Medical Conferences
  • 211 Specialties
  • 20664 Organizers
  • 129340 Speakers
  • 151 Countries
  • 4012 Cities
35195+
CME Conference Registrations Sold

SEARCH NEWS
Or

Hematology & Oncology News (747)

Fri, Sep 21, 2018 - Physician burnout is associated with increased risk of patient safety incidents, poorer quality of care due to low professionalism, and reduced patient satisfaction, according to a review published online Sept. 4 in JAMA Internal Medicine. Read More >
Research Links Doctor Burnout to Patient Safety Incidents
Thu, Sep 20, 2018 - There are fears that huge sums are being raised on crowdfunding sites for alternative cancer treatments that are not backed by evidence, according to a feature article published online Sept. 12 in The BMJ. Read More >
Crowdfunding for Cancer Tx Could Exploit Vulnerable Patients
Thu, Sep 20, 2018 - On average, hospitals mark up drugs by 479 percent of their cost, according to a report from The Moran Company, commissioned by the Pharmaceutical Research and Manufacturers of America. Read More >
Hospitals Charge 479 Percent of Cost of Drugs on Average
Thu, Sep 20, 2018 - Risk of cardiotoxicity is higher for patients receiving trastuzumab and/or anthracyclines for the treatment of breast cancer, according to a study published in the Aug. 1 issue of JACC: Cardiovascular Imaging. Read More >
Cardiac Monitoring Needed for High-Risk Breast Cancer Patients
Thu, Sep 20, 2018 - Although there are many demands on residents, taking advantage of paid vacation time is one of the perks and should be maximized, according to an article published in the American Medical Association's AMA Wire. Read More >
Residents Should Take Advantage of Paid Time Off
Thu, Sep 20, 2018 - A lawsuit filed Tuesday in California claims that pharmaceutical company AbbVie used cash, gifts, and services to induce doctors to overprescribe the widely used drug Humira (adalimumab), ignoring the medicine's potentially lethal side effects. Read More >
California Lawsuit Claims AbbVie Paid Doctors to Prescribe Humira
Thu, Sep 20, 2018 - Rivaroxaban does not lower risk of symptomatic venous thromboembolism and related death in medical patients after hospital discharge, compared to placebo, according to a study published in the Sept. 20 issue of the New England Journal of Medicine. Read More >
No Clear Benefit for Rivaroxaban After Hospital Discharge
Wed, Sep 19, 2018 - In 2016 the age-standardized prevalence of insufficient physical activity was 27.5 percent, according to a study published in the October issue of The Lancet Global Health. Read More >
Global Prevalence of Insufficient Activity 27.5 Percent